Increased plasma adrenomedullin levels in hemodialysis pais present in approximately 10% of patients on maintetients with sustained hypotension.
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nance hemodialysis (HD) and may be more prevalent
Background. Sustained hypotension in end-stage renal disin long-term HD patients [1] . Although the prevalence ease patients is characterized, despite an overactivation of the of this complication is low, these patients require a subsympathetic and renin-angiotensin systems, by decreased vascular resistance and a blunted vascular response to pressor stantial amount of medical and nursing care during and
stimuli. An increased production of one or more vasodilator after dialysis to control hypotensive symptoms. The substances might play a role in the reduced vascular resistance pathophysiology of chronic hypotension in uremic paand response to pressor stimuli in these patients. We evaluated tients still remains unknown, but several potential mechthe possible role of an increased production of nitric oxide and/ anisms have been implicated: the autonomic neuropathy or adrenomedullin (ADM) in the pathophysiology of chronic hypotension in hemodialysis (HD) patients. present in uremia [2] , a blunted pressor response to norMethods. Three groups of hypotensive (N ϭ 9), normotenepinephrine, secondary to an impaired vascular adrenosive (N ϭ 10), and hypertensive (N ϭ 9) HD patients were ceptor function [3] [4] [5] , a decreased pressor response to included in the study. Plasma renin activity (PRA) and plasma angiotensin II (Ang II) infusion associated with reduced levels of catecholamines, ADM, nitrite/nitrate (an estimator of nitric oxide production), tumor necrosis factor (TNF), and Ang II receptor density [6] , or the increased production interleukin-1␤ (IL-1␤) were measured. Plasma volume and left of nitric oxide reported in uremia [7] , among others. ventricular ejection fraction (LVEF) were also evaluated.
Much evidence indicates that the sympathetic nerve
Results. Plasma levels of nitrite/nitrate and ADM were eleactivity is increased in uremia. Plasma catecholamine vated in HD patients with respect to the reference values in normal subjects. Plasma ADM levels, but not nitrite/nitrate levels have been reported to be elevated in hemodialyzed levels, were higher in hypotensive (368.1 Ϯ 25.4 pg/mL) than patients [3] [4] [5] . Although plasma catecholamine levels in normotensive (225 Ϯ 9.9 pg/mL) and hypertensive HD patients uremic patients cannot be considered a reliable index (278.2 Ϯ 15.5 pg/mL, P Ͻ 0.01). When considering hypotensive of sympathetic activity, studies using microneurographic and normotensive patients together, the mean blood pressure inversely correlated with time on HD (r ϭ Ϫ0.53, P Ͻ 0.05) techniques confirmed that sympathetic overactivity is ofand plasma ADM levels (r ϭ Ϫ0.78, P Ͻ 0.01).
ten present in uremia [8] . Hypotensive HD patients disConclusions. Plasma ADM and nitrite/nitrate levels are inplay even higher plasma catecholamine levels than norcreased in HD patients, but only ADM levels were higher motensive uremic patients [3] [4] [5] , whereas the pressor in hypotensive than in normotensive and hypertensive HD patients. The higher plasma levels of this peptide in hypotensive response to exogenous norepinephrine infusion is markpatients and its inverse correlation with mean arterial pressure edly blunted in these patients when compared with norsuggest that ADM may be involved in the pathophysiology of motensive HD patients [3, 4] , suggesting the presence chronic hypotension in HD patients.
of a postsynaptic vascular resistance to the sympathetic stimuli. This peripheral vascular resistance to the effects of norepinephrine has been ascribed to a reduced vascuChronic hypotension, defined as a systolic blood preslar ␣-adrenoceptor number and/or function [3, 5] . Plasma sure lower than 100 mm Hg between dialysis sessions, Ang II levels have been reported to be elevated in hypotensive HD patients [6, 9] , but the pressor response to blunted. Thus, it is tempting to speculate that an inments in the previous three months. The causes of ESRD in this group were chronic glomerulonephritis (N ϭ 2), creased production/release of one or more vasodilator substances, as opposed to the vascular effects of norepitubulointerstitial nephritis (3), polycystic kidney disease (2) , and undefined (2) . nephrine or Ang II, might be implicated in the pathophysiology of this disorder.
The normotensive group included 10 normotensive HD patients (6 men and 4 women, mean age 43.8 Ϯ 15 Nitric oxide production has been reported to be increased in uremia, and it has been postulated that it years, mean time on HD 7.33 Ϯ 7.5 years, mean Ϯ sd) with a predialysis blood pressure Յ145/90 mm Hg for plays a role in the uremic bleeding diathesis and HDassociated hypotension [7] , although the possible role of the previous three months. The causes of ESRD were chronic glomerulonephritis (N ϭ 2), tubulointerstitial this molecule in sustained hypotension in uremia has not been studied thus far.
nephritis (3), polycystic kidney disease (1), nephrosclerosis (1), hemolytic uremic syndrome (1), and undeAdrenomedullin (ADM) is an endogenous 52-amino acid peptide first isolated from human pheochromocyfined (2) . The hypertensive group included nine hemodialyzed toma that possesses potent vasodilating properties [10] . There is increasing evidence that this peptide plays a patients (6 men and 3 women, mean age 43.9 Ϯ 13.3 years, mean time on HD 5.99 Ϯ 4.6 years, mean Ϯ sd). role as a paracrine/autocrine factor in the regulation of the cardiovascular system [11] . ADM-like immunoreacHypertension was defined as predialysis blood pressure levels consistently Ͼ145/90 mm Hg or the need for antitivity is found in numerous tissues, including adrenal medulla, heart, brain, lungs, and kidneys, as well as in hypertensive treatment for the previous three months. The causes of renal failure were tubulointerstitial nephrihuman plasma [12] . Plasma levels of ADM have been reported to be elevated in certain disease states in hutis (N ϭ 3), nephrosclerosis (2), chronic glomerulonephritis (2), lupus nephritis (1), and undefined (1). mans, including essential hypertension, chronic renal failure, congestive heart failure, liver cirrhosis with asciNone of the patients were anephric, had evidence of cardiac or pericardial disease, or suffered from diabetes tes, and chronic obstructive pulmonary disease with hypmellitus, chronic obstructive pulmonary disease, hepatic oxia [13] . It has also been recently reported that ADM dysfunction, or other systemic diseases, such as amyexerts a hypotensive effect in humans at the plasma levels loidosis. All subjects had normal thyroid function. None observed in some disorders of the circulation [14] . Fiof the hypotensive or normotensive patients received nally, plasma ADM levels have been consistently found antihypertensive treatment, and no patients received vato be markedly increased in patients with chronic renal sodilatory drugs. Antihypertensive treatment was withfailure [13, 15, 16] and in HD patients [17] [18] [19] [20] .
drawn one week before the study in hypertensive-treated We hypothesized that an increased production of one patients. All patients underwent four-hour HD three or more vasodilator substances might be the underlying times weekly with volumetrically controlled ultrafiltramechanism of the reduced vascular response in sustained tion devices and bicarbonate-containing dialysate, and hypotension in uremia, whereas the overactivation of the medication prescribed included phosphate binders, the sympathetic and renin-angiotensin systems would vitamins, iron supplements, and recombinant human be a compensatory phenomenon. Actually, an increased erythropoietin. All subjects were studied after giving synthesis and/or plasma levels of several endotheliumtheir written informed consent, and the study was apderived vasodilators such as nitric oxide [7] , prostacyclin proved by the ethical committee of our institution. [21] , and ADM [13] [14] [15] [16] [17] [18] [19] [20] have been reported in uremia.
Studies were performed between 8 a.m. and 9 a.m., This study was designed to assess the possible role of after overnight fasting, and prior to a regularly scheduled two vasodilator substances, nitric oxide and ADM, in the HD session. A cannula was inserted in an anterocubital pathogenesis of chronic hypotension in hemodialyzed vein for blood sampling. Subjects were placed in a supine patients.
position for at least 45 minutes before measuring blood pressure and blood sampling.
METHODS
Blood pressure was measured three times within a Twenty-eight patients with end-stage renal disease five-minute interval with a mercury sphygmomanometer, (ESRD) on maintenance HD (9 hypotensive, 10 normoand the mean of the three readings was considered. Mean tensive, and 9 hypertensive patients) were included in arterial pressure (MAP) was calculated as the diastolic this study.
plus one third of the pulse pressure. The hypotensive group included nine patients (4 men Blood samples were collected in prechilled tubes, and 5 women, mean age 51.1 Ϯ 13 years, mean time on which were promptly centrifuged at 4ЊC. Plasma cate-HD 12.1 Ϯ 6.5 years, mean Ϯ sd). Chronic hypotension cholamine levels were measured by radioimmunoassay was defined as a systolic blood pressure Յ100 mm Hg (RIA; IBL Laboratories, Hamburg, Germany; reference values in our laboratory were as follows: plasma epinephpredialysis in at least 80% of blood pressure measure- rine levels 44 Ϯ 38 pg/mL, plasma norepinephrine levels values in our laboratory for TNF-␣ were 13.8 Ϯ 3 pg/mL 253 Ϯ 114 pg/mL). Plasma renin activity (PRA) was and for IL-1␤ were 44.7 Ϯ 4.4 pg/mL. measured by RIA of Ang I generated by incubation at Plasma volume by means of the isotope dilution techpH 7.4 at 37ЊC (Incstar Corp., Stillwater, MN, USA; nique using 131 I-labeled albumin and left ventricular ejecreference values in normal control subjects 0.28 Ϯ 0.2 tion fraction (LVEF) by isotopic ventriculography were ng/mL · h). Plasma nitrite/nitrate levels, considered as also measured. an estimate of nitric oxide production, were measured Data are expressed as means Ϯ sem. Comparisons by a fluorometric technique, as previously described (ref- between the three groups of patients were analyzed by erence plasma values in our laboratory 37 Ϯ 14 nmol/ using a one-way analysis of variance. Correlation coeffimL) [22] . Intra-assay and interassay coefficients of variacients were calculated by the Spearman rank order corretion were 8.4 and 14.8%, respectively. The plasma ADM lation test. Significance was defined as a P Ͻ 0.05. concentration was measured by RIA using a commercial kit (Phoenix Pharmaceuticals, Mountain View, CA, RESULTS USA), as previously described [23] . Briefly, after extracSystolic, diastolic, and mean blood pressures were sigtion of ADM on "Sep-Pak C18" cartridges (Waters Asnificantly different in the three groups of patients, as sociates, Milford, MA, USA), plasma samples (2 mL) expected (P Ͻ 0.01). No significant differences with rewere acidified with 4% acetic acid (3 mL) and applied spect to age or sex were observed among the three twice to cartridges preactivated with methanol, distilled groups. Although the mean time on HD was longer in water, and 4% acetic acid. Cartridges were then washed hypotensive patients than in normotensive and hypertenwith distilled water and 25% ethanol, and ADM was sive patients, the difference failed to reach statistical eluted with 4 mL acetic acid glacial in 86% ethanol. The significance (Table 1) . No significant differences were eluted ADM was then dried and reconstituted for RIA.
observed in interdialysis weight gain between the three The recovery rate for the extraction procedure was 79%, groups. as determined by the addition for 125 I-ADM to plasma.
Plasma norepinephrine levels and PRA were inMaximum binding of the anti-ADM antibody in the RIA creased in the whole group of HD patients with respect to was 40.6%. Intra-assay and interassay coefficients of varithe reference values. No significant differences in plasma ation were 12.4 and 13.6%, respectively. Dilution curves levels of epinephrine, norepinephrine, or PRA were obobtained from plasma extracts paralleled the standard served between the three groups of patients. Plasma curve. In our laboratory, mean plasma ADM levels in nitrite/nitrate levels were increased in hemodialyzed panormal control subjects were 127 Ϯ 58 pg/mL. tients with respect to the reference values, but again, no Serum levels of tumor necrosis factor-␣ (TNF-␣) and significant differences were observed between the three interleukin-1␤ (IL-1␤) were measured by immunoradiogroups of patients. Plasma ADM levels were also elemetric (Medgenix Diagnostics, Fleuris, Belgium) and envated in uremic patients with respect to values in normal zyme-linked immunoabsorbent assays (DRG Instruments, Marburg, Germany), respectively. Reference subjects. In addition, ADM levels were more elevated tained hypotension in HD patients. In contrast, plasma in hypotensive HD patients than in normotensive (P Ͻ nitrite/nitrate levels, an estimator of nitric oxide produc-0.01) and hypertensive (P Ͻ 0.01) HD patients (Table 1) .
tion, were similar in the three groups of patients, arguing Serum levels of TNF-␣ were similar in the three groups against a possible role for this substance in the pathoof patients, whereas IL-1␤ levels were significantly lower physiology of sustained hypotension (increased release) in hypertensive patients than in hypotensives (P Ͻ 0.05) and hypertension (decreased production) in uremia. and in the limit of the significance versus the normotenIn sustained hypotension in uremia, a decreased vascusive group (P ϭ 0.066). Plasma volume and LVEF were lar resistance associated with an overactivation of the not significantly different among the three groups of pressor systems (sympathetic and renin-angiotensin syspatients (Table 1) . tem) and a blunted pressor response to norepinephrine When considering all patients together, the MAP was [3, 4] and Ang II [6] have been observed. In this study, inversely correlated with time on HD (r ϭ Ϫ0.40, P Ͻ plasma norepinephrine levels and PRA tended to be 0.05), plasma ADM levels (r ϭ Ϫ0.423, P Ͻ 0.05), and higher in hypotensive patients when compared with nor-IL-1␤ (r ϭ Ϫ0.56, P Ͻ 0.01). When considering only motensive and hypertensive patients, in agreement with normotensive and hypotensive patients together, MAP previous results of our group [5, 9] , as well as others was inversely correlated with time on HD (r ϭ Ϫ0.53, [3, 6] , suggesting the presence of an overactivation of P Ͻ 0.05; Fig. 1 ) and plasma ADM levels (r ϭ Ϫ0.78, these pressor systems in hypotensive HD patients. These P Ͻ 0.01; Fig. 2 ). Plasma nitrite/nitrate levels showed no observations raised the possibility that an increased biocorrelation with MAP. Neither plasma nitrite/nitrate nor synthesis and/or release of one or more vasodilator subplasma ADM levels showed a relationship with age, time stances might be involved in the pathogenesis of this on HD, interdialysis weight gain, plasma norepinephrine disorder, whereas the activation of the pressor mechalevels, or PRA, serum levels of TNF or IL-1␤, plasma nisms would be a secondary phenomenon in order to volume or LVEF, either when considering the whole compensate for the excessive vasodilation. group of HD patients or only normotensive and hypotenNoris et al reported that nitric oxide biosynthesis was sive patients. increased in uremia, and they postulated that this enhanced nitric oxide production may contribute to the DISCUSSION platelet dysfunction observed in uremia, as well as to Our study confirms the results of previous studies in other complications such as HD-associated hypotension which plasma nitrite/nitrate and ADM levels are in- [7] . Our results demonstrate that plasma nitrite/nitrate creased in HD patients. The main finding of our study is markedly increased in uremic patients, suggesting that was that in HD patients with sustained hypotension, nitric oxide biosynthesis is in fact increased in uremia, plasma ADM levels are further increased with respect in agreement with the previous study. However, the obto normotensive and hypertensive HD patients and that servation that plasma levels of nitrite/nitrates in hypotenplasma ADM levels inversely correlated with MAP in sive patients were similar to those found in normotensive HD patients. These results suggest that this vasodilator and hypertensive HD patients, and their lack of relationship with MAP argues against a role for an increased peptide may be involved in the pathophysiology of sus-nitric oxide production in the pathophysiology of susonly normotensive and hypertensive patients who were much older than those in our study, and in contrast to tained hypotension in uremic patients. Conversely, plasma levels of nitrite/nitrate may not be representative ours, a third of them also had heart failure and 24% of them diabetic nephropathy, two conditions associated of local nitric oxide synthesis, and an increased nitric oxide production in some vascular beds as a possible with increased plasma ADM levels [13, 28] . On the other hand, our hypertensive patients showed higher, although mechanism of sustained hypotension cannot be completely ruled out from our study. Another word of caunonsignificant, plasma ADM levels than the normotensive controls (23% increase). This increase was equivation in interpreting these results is the fact that because of the accumulation of nitrates in chronic renal failure, lent to the one reported by Toepfer et al in their subset of uncomplicated hypertensive HD patients (23%) [20] . the relative contribution of diet and endogenous synthesis of nitric oxide in the plasma levels of nitrite/nitrates
The mechanism through which plasma ADM levels are further increased in hypotensive HD patients is unis difficult to establish in dialysis patients.
Previous studies reported that plasma ADM levels are known. No differences in plasma volume were observed between the three groups of patients, whereas ADM increased in chronic renal failure [13, 15, 16] and in HD patients [17] [18] [19] [20] . Our results confirm that plasma ADM levels showed no relationship with plasma volume, arguing against a role for hypervolemia in the increase in levels are increased in these patients, although the cause or causes for these increased ADM levels are still unplasma ADM levels in the hypotensive group. LVEF was preserved in all our patients and was similar in the known. The main source of ADM in the circulation and its metabolism in humans has not been conclusively three groups of patients, ruling out the possibility that cardiac dysfunction was the cause of the increased shown [24] . The ubiquitous production of ADM in the cardiovascular system suggests that it may have a local plasma ADM levels in hypotensive patients. Serum levels of IL-1␤ and TNF-␣ in our hypotensive patients were (autocrine and paracrine) vasodilatory role. In this sense, it is interesting to point out that the vasodilatory effects similar to the normotensive patients, and the levels of these cytokines showed no relationship with plasma are more prominent in organs in which this peptide is expressed, for example, lung, heart, kidney or adrenal ADM levels, arguing against a role for these cytokines in the increased plasma ADM levels in hypotensive pagland, but not in skeletal muscle or skin [25] . Although the levels of ADM are related to creatinine clearance tients. ADM levels have been shown to correlate with parameters of sympathetic activity in several clinical situ- [16] , the high levels of ADM in renal failure do not seem to be simply caused by a decreased renal clearance, but ations [15, 29, 30] . As hypotensive HD patients had sympathetic overactivation [3] [4] [5] , it is possible that this inalso to an increased production. The regulation of ADM is complex and influenced by circulating hormones, creased sympathetic activity may be involved in the increased production of ADM in this subset of patients. growth factors, cytokines, IL-1, TNF, and lipopolysaccharide [26, 27] . The recent demonstration that ADM However, plasma norepinephrine levels showed no relationship with ADM levels in our study, arguing against levels decrease after isolated ultrafiltration in HD patients suggests that body volume is also involved in the this possibility. The mechanism or mechanisms by which plasma ADM levels are increased in hypotensive HD regulation of this peptide [19] . As most of these previously mentioned factors are altered in HD patients, it patients deserves further investigation, whereas the confirmation or not that ADM plays a role in the reduced is possible that the increased plasma ADM levels in HD patients have a multifactorial origin related to the vascular resistance and blunted vascular resistance to pressor stimuli in sustained hypotension in HD patients abnormalities associated with this situation. Plasma levels of ADM were higher in hypotensive HD patients needs to be explored by specific antagonists of this peptide. with respect to the normotensive (63% increase) and hypertensive patients (32% increase), suggesting that
The vasodilator effects of ADM are mediated through the interaction with specific receptors located in target ADM production was further enhanced in this subset of patients. This observation, together with the inverse organs. It has been recently reported that the calcitoninreceptor-like receptor can function as either a calcitoninrelationship between plasma ADM levels and MAP, suggests that this vasodilator hormone can be involved in gene-related peptide (CGRP) or an ADM receptor, depending on which members of the receptor-activitythe pathophysiology of sustained hypotension in uremia. Previous studies failed to find this relationship in HD modifying proteins (RAMPs) are expressed. Thus, the calcitonin-receptor-like receptor has two alternative patients [17, 20] . In the first study, which failed to find any relationship between MAP and ADM levels, the pharmacological profiles that are conferred by the accessory proteins RAMP1 (producing the CGRP receptor) selection criteria were not precise and hypotensive patients did not seem to be included [17] . The study done and RAMP2 (producing the ADM receptor) [31] . The vasodilator effects of ADM can be mediated by a direct by Toepfer et al reported a positive relationship between MAP and plasma ADM levels [20] . That study included effect on vascular smooth muscle cells to increase intra- Engl J Med 327:1912 -1918 , 1992 induced vasoconstriction in several vascular beds is an-9. Esforzado N, Cases A, Bono M, Calls J, Gaya J, Rivera F:
other postulated mechanism [35] . The latter mechanism
Vasoactive hormones in uraemic patients with chronic hypotenis particularly interesting, as a blunted pressor response 
